Charles River has been riding rough waters in 2024, and as the CRO’s CEO predicted, the third quarter proved no exception. | ...

Charles River Laboratories International Inc (NYSE:CRL) reported third-quarter 2024 revenue of $1.01 billion on Wednesday, a ...

Have you evaluated the performance of Charles River Laboratories' (CRL) international operations for the quarter ending September 2024? Given the extensive global presence of this medical research ...

In another sign that biopharma companies are slowing their early R&D efforts, Charles River Laboratories is shuttering more than a dozen sites. The service provider is working on “consolidating ...

A charter company working for Charles River Laboratories was fined for improperly shipping long-tailed macaques into Canada ...

Shipments of research monkeys by Charles River Laboratories, one of the largest U.S. clinical research organizations, have ...

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

UBS raised the firm’s price target on Charles River (CRL) to $250 from $240 and keeps a Buy rating on the shares post the earnings ...

Charles River Labs (CRL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tejas Savant from Morgan Stanley maintained a Hold rating on the ...

WILMINGTON, Mass. — WILMINGTON, Mass. — Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $69.7 million. On a per-share basis, the Wilmington, ...

The Charles River is ready for the rowers. Starting today, more than 12,000 athletes and tens of thousands of fans will head to Greater Boston’s iconic river for the three-day Head of the ...